Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease
Toxins · 2024
DOI: 10.3390/toxins16110495 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, 2024. Verfasst von Elisabet Coll und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servei de Nefrologia, Fundacio Puigvert, 08025 Barcelona, Spain. Hauptthemen laut MEDLINE: Dysbiosis, Renal Insufficiency, Chronic, Gastrointestinal Microbiome, Anemia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The gut dysbiosis present in chronic kidney disease (CKD) has been associated with anemia. Factors such as the accumulation of gut-derived uremic toxins, increased gut barrier permeability-induced inflammation, and a reduced intestinal production of short-chain fatty acids (SCFAs), all associated with changes in the intestinal microbiota composition in CKD, may lead to the development or worsening of anemia in renal patients. Understanding and addressing these mechanisms related to gut dysbiosis in CKD patients can help to delay the development of anemia and improve its control in this population. One approach is to avoid or reduce the use of drugs linked to gut dysbiosis in CKD, such as phosphate binders, oral iron supplementation, antibiotics, and others, unless they are indispensable. Another approach involves introducing dietary changes that promote a healthier microbiota and/or using prebiotics, probiotics, or symbiotics to improve gut dysbiosis in this setting. These measures can increase the presence of SCFA-producing saccharolytic bacteria and reduce proteolytic bacteria, thereby lowering the production of gut-derived uremic toxins and inflammation. By ameliorating CKD-related gut dysbiosis, these strategies can also improve the control of renal anemia and enhance the response to erythropoiesis-stimulating agents (ESAs) in ESA-resistant patients. In this review, we have explored the relationship between gut dysbiosis in CKD and renal anemia and propose feasible solutions, both those already known and potential future treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servei de Nefrologia, Fundacio Puigvert, 08025 Barcelona, Spain.
- Anemia Working Group of the Spanish Society of Nephrology, 39008 Santander, Spain.
- Servicio de Nefrología, Hospital Ribera-Polusa, 27004 Lugo, Spain.
- Ressearch Net RICORS 2030 Instituto de Salud Carlos III ISCIII, 28029 Madrid, Spain.
- Nephrology Department, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.
- Medicine Department, Facultad de Medicina, Research Institute Puerta de Hierro Segovia de Arana (IDIPHISA), Universidad Autónoma de Madrid, 28029 Madrid, Spain.
ORCID-Profile: Secundino Cigarran, Jose Portolés, Aleix Cases
Zitieren
APA
Coll, E., Cigarran, S., Portolés, J., & Cases, A. (2024). Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease. Toxins. https://doi.org/10.3390/toxins16110495
Vancouver
Coll E, Cigarran S, Portolés J, Cases A. Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease. Toxins. 2024. doi:10.3390/toxins16110495
BibTeX
@article{Coll2024,
author = {Coll, Elisabet and Cigarran, Secundino and Portolés, Jose and Cases, Aleix},
title = {Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease},
journal = {Toxins},
year = {2024},
doi = {10.3390/toxins16110495}
}
EUVIMED